Loading... 2 0 20 0 false
Credit Name
Cecily Forsyth
Full Name
Forsyth, Cecily
Variants
Forsyth, Cecily J
 
Main Affilation
Central Coast Local Health District
 
Department
 
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Haematology
Subject:  Drug Therapy

Results 1-6 of 6 (Search time: 0.003 seconds).

PreviewIssue DateTitleAuthor(s)
1Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaForsyth, Cecily J Minson, A.G.Cummins, K.Fox, L.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
2Feb-2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.Yeung, D.Osborn, M.White, D.Branford, S.Braley, J.Herschtal, A.Kornhauser, M.Issa, S.Hiwase, D.Hertzberg, M.Schwarer, A.Filshie, R.Arthur, C.Kwan, Y.L.Trotman, J.Forsyth, Cecily J Taper, J.Ross, D.M.Beresford, J.Tam, C.Mills, A.K.Grigg, A.Hughes, T.
3Jul-2014Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapyForsyth, Cecily J Paidas, M.J.Quere, I.Rodger, M.
4Jul-2012The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseForsyth, Cecily J Best, O.G.Che, YSingh, N.Christopherson, R.I.Mulligan, S.P.
5Feb-1996Thalidomide responsive chronic pulmonary GVHDForsyth, Cecily J Cremer, P.D.Torzillo, P.Iland, H.J.Young, G.A.
6Oct-1995Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young menForsyth, Cecily J Adams, M.R.Jessup, W.Robinson, J.Celermajer, D.S.